Best Online Menopause Clinic for Painful Sex in 2026

What we actually verified

What is the best online menopause clinic for painful sex?

Our matrix scores each clinic on four GSM-specific criteria: symptom fit, treatment menu, price and access clarity, and clinical-safety fit. Scores are editorial fit ratings, not medical outcome claims.

Last verified: May 27, 2026. Sources at bottom of page.

Two patterns worth seeing before you scroll past the table.

First, Evernow’s bundled vaginal cream changes the math.A cash-pay reader who medically qualifies and picks Evernow’s 3-month membership pays $129 for 90 days of membership access, with vaginal estradiol cream listed as included at no added medication cost. That is the lowest verified path to an FDA-approved cream in this comparison. Most “best of” pages have not updated to reflect this.

Second, MyMenopauseRx is the only clinic in our matrix listed as the named telehealth partner on Osphena’s manufacturer site (Duchesnay USA). If you specifically want to discuss or be prescribed the FDA-approved oral pill for painful sex (ospemifene, brand name Osphena), the cleanest insurance-friendly path goes through MyMenopauseRx.

Why does sex hurt after menopause?

You are not broken. The tissue changed.

Estrogen keeps vaginal tissue thick, stretchy, and naturally lubricated. When estrogen drops — in the years before your last period (perimenopause), after your last period (postmenopause), or suddenly from surgery or cancer treatment — that tissue thins. The medical term is dyspareunia (painful intercourse). The broader condition that drives it after menopause is GSM, also called vulvovaginal atrophy (VVA). You will see all three words used. They overlap.

Three things many women wish someone had said earlier:

• Lube treats friction. It does not target the tissue change. If you are using lube and sex still hurts, the lube is not failing. The tissue needs something else.
• GSM is chronic and can progress without treatment. That is not meant to scare you. It is meant to give you permission to stop waiting.
• Most women with GSM never bring it up with a clinician. You are not alone in never having asked.

The Menopause Society and ACOG both classify GSM as undertreated and recommend that clinicians ask about it proactively. If yours didn’t, that is on them — not you.

What treatments actually treat painful sex after menopause?

Low-dose vaginal estrogen — the first-line prescription option for GSM

Tiny amounts of estrogen applied directly to vaginal tissue. Very little gets absorbed into the bloodstream — that is the whole point. FDA-approved forms include:

• Estradiol vaginal cream (generic estradiol, brand Estrace). Generic retail from about $38 per tube via Drugs.com pricing; brand from about $345. GoodRx and Cost Plus Drugs often bring the generic down significantly.
• Vaginal estradiol tablet (Vagifem, generic Yuvafem). A small tablet inserted with an applicator. Retail typically $90–$370 for 8 tablets depending on brand and pharmacy.
• Vaginal estradiol insert (Imvexxy). Softgel-style insert.
• Vaginal estradiol ring (Estring). Inserted by you or a clinician; releases estrogen over 90 days.
• Conjugated estrogen vaginal cream (Premarin vaginal cream). Older formulation, still in use.

Most women notice improvement in 2 to 12 weeks of consistent use. If pain is still significant after about 12 weeks of correct use, reassess with a clinician.

Prasterone / Intrarosa — the non-estrogen vaginal insert

A once-daily vaginal insert containing prasterone, a plant-derived form of DHEA. Your body converts it locally into small amounts of estrogen and androgen right where you need it. FDA-approved specifically for moderate-to-severe painful sex due to menopause. Per DailyMed labeling, exogenous estrogen is contraindicated in women with a known or suspected history of breast cancer, and Intrarosa has not been studied in women with a history of breast cancer.

Retail is steep — about $316 to $411 for 28 inserts — but the manufacturer’s savings program can bring the copay to as little as $35 for 28 inserts for eligible commercially insured patients.

Ospemifene / Osphena — the oral pill

The only FDA-approved oral pill for painful sex due to menopause. A SERM — acts like estrogen in vaginal tissue but differently elsewhere. Once-daily tablet. Carries a boxed warning about endometrial cancer and cardiovascular disorders. Cash retail starts around $258 for 30 tablets; the Osphena At Home savings program offers as little as $35 for 30 tablets for commercially insured patients. MyMenopauseRx is the partnered telehealth route named on the manufacturer’s own site.

Vaginal moisturizers and lubricants — the OTC helpers

Lubricants (K-Y, Sliquid, Astroglide, silicone-based products) reduce friction during sex. Moisturizers (Replens, Hyalo Gyn) hydrate tissue between sex when used 2 to 3 times per week. Mayo Clinic recommends both as first-line comfort tools — but they do not address the underlying tissue change. If you have already tried them and still hurt, tell your clinician that.

Pelvic floor physical therapy — when this is also a muscle problem

Sometimes the cause is not only tissue thinning. Tight pelvic floor muscles can clamp at the vaginal opening and cause sharp pain even afterthe tissue is restored with estrogen. If you have done 12 weeks of appropriate treatment and pain is still there — especially burning at the entrance or a “wall” — pelvic floor PT is the next step. Online menopause clinics will typically refer you out.

A note on laser (“vaginal rejuvenation”)

Be cautious. The FDA has not approved or cleared energy-based vaginal devices for menopause symptoms, urinary incontinence, or sexual function. ACOG and The Menopause Society do not recommend them as first-line. If a clinic leads with laser, that is a flag, not a feature.

How much does online treatment for painful sex cost in 2026?

This is where most readers get tripped up. They compare a $49/month membership against a $39.99/month cream against a $250 visit fee and assume they are the same thing. They are not. Three numbers actually matter:

1. The visit or membership fee — what the platform charges you to access a clinician.
2. The medication cost — separate at most providers, and bigger than the membership at many.
3. Labs (if any) — most menopause platforms do not require labs for GSM; some do for systemic care.

90-day cost-to-comfortable for the most common GSM regimen

What you will actually spend in the first 90 days to start an FDA-approved vaginal cream protocol:

If you are insured, the math flips. Midi’s “highest sticker” turns into your lowest out-of-pocket because both the visit and the medication run through your insurance.

Is online vaginal estrogen safe? What changed in 2025–2026

This is the change most “best of” pages have not reflected. The 2002 Women’s Health Initiative (WHI) study spooked a generation of women off hormone therapy. That trial used older women (average age 63) on older synthetic progestin formulations, and the findings were applied broadly to women in their 40s and 50s starting modern bioidentical hormones. The result: use of menopausal hormone therapy among postmenopausal U.S. women dropped from 26.9% in 1999 to 4.7% by 2020, according to JAMA Health Forum.

Low-dose vaginal estrogen specifically has always had very limited systemic absorption. A 2025 Danish registry analysis published in Strokefound that vaginal estrogen tablets were not associated with increased recurrent ischemic stroke risk among postmenopausal women with a prior stroke. The AUA, AUGS, and SUFU all formally supported removing the warning. The Menopause Society said the boxed warning had been a “deterrent to the use of low-dose vaginal estrogen, which is a safe and effective therapy” for GSM.

What this means for your provider conversation: your clinician should be talking about your age, your time since menopause, your formulation, and your personal history — not reciting 2010-era boxed warnings. If your clinician is still talking like it is 2010, ask why.

FDA-approved vaginal estrogen vs. compounded: what is the difference?

Three terms that get confused on purpose

• FDA-approved finished medication: The actual cream, tablet, ring, or insert you receive has passed FDA review. Dosing is consistent batch-to-batch. Insurance often covers it.
• Bioidentical: Chemically identical to the hormones your body makes. Bioidentical does NOT mean compounded. Many FDA-approved hormones are bioidentical. The wellness marketing has blurred this for years.
• Compounded: Mixed for you at a compounding pharmacy. Can contain FDA-approved active ingredients without being an FDA-approved finished medication.

When compounded is appropriate

• You have a documented allergy to an inactive ingredient in an FDA-approved product.
• You need a dose or form that does not exist commercially.
• Your clinician has identified a specific medical reason — not just a preference.

For the painful-sex use case, FDA-approved vaginal estrogen exists in multiple forms. Unless your clinician has a specific reason to compound, the FDA-approved route should come first.

If you have a history of breast cancer

What the medical bodies actually say

ACOG (Committee Opinion #659, carried forward into the 2021 Clinical Consensus on urogenital symptoms in women with a history of estrogen-dependent breast cancer): non-hormonal first. If non-hormonal fails, low-dose vaginal estrogen may be considered, with oncology involvement. The Menopause Society echoes this in their position statement.

Translation: A clinic that prescribes you vaginal estrogen without asking about your oncology team is a clinic that did not do its job.

Which online clinics handle this well

The providers with the longest consult times and the most explicit care-coordination language are Midi Health, Gennev, and Pandia Health (which uses Menopause Society Certified Practitioners, the MSCP credential). If you are a breast cancer survivor, start with one of these — not with a 5-minute questionnaire model.

A few practical things to know:

• Vaginal moisturizers (Replens, Hyalo Gyn) and lubricants are appropriate to start now, before any clinic appointment.
• Lidocaine 4% applied to the vestibule before sex has small-trial support. A Journal of Clinical Oncology study of breast cancer survivors reported 37 of 41 participants (90%) had comfortable penetration. This is a discussion point for your oncologist or gynecologist, not a self-treatment instruction.
• Ospemifene (Osphena) is a SERM, not vaginal estrogen. Breast-cancer survivors should ask their oncologist and gynecologist whether ospemifene is appropriate for their specific history.
• Prasterone (Intrarosa): per its label, exogenous estrogen is contraindicated in women with known or suspected breast cancer history, and Intrarosa has not been studied in this population.

The honest version: if you have current or active breast cancer treatment, an online menopause clinic should not be your primary provider for this decision. Use this page to prepare for the conversation with your oncologist and gynecologist, not to replace it.

When to see an in-person doctor instead

The Menopause Society maintains a free, searchable directory at menopause.org/find-a-menopause-practitioner to locate clinicians with the MSCP credential near you.

Provider deep-dives: who wins, who should skip, and why

Each provider gets the same structure: verdict, what we verified, who should pick this, who should not, and the damaging admission that earns the recommendation.

A note on links: as of May 27, 2026, The HRT Index does not have active affiliate partnerships with every provider below. Where we add one later, the link will be labeled. For now, every provider link goes directly to the provider’s site so you can verify what we said. Full affiliate disclosure →

Evernow — best cash-pay path with vaginal cream included

Verified (May 27, 2026):

• Membership: $49/mo month-to-month; $129 for 3 months (~$43/mo); ~$420 for 1 year (~$35/mo)
• Vaginal estradiol cream included at no added medication cost for medically eligible patients on the 3-month and 1-year membership tiers (value Evernow publicly states at $120–$480)
• FDA-approved estradiol (cream, tablets, patches) and micronized progesterone
• App-based platform with ongoing messaging
• Optional insurance-eligible video visits ($150 self-pay)
• All 50 states + D.C.

Why we ranked it #1 for this query:For GSM-driven painful sex, vaginal estrogen is the core treatment protocol. Evernow makes that protocol the cheapest legitimate path in this comparison. Combined with all-50-states availability, FDA-approved medication, and a $35/mo entry, it answers the most common version of “I just want this treated and I can’t pay $400 a tube.”

Pick Evernow if: You are paying cash; your symptoms are GSM-focused; you want ongoing messaging access; you do not need a scheduled 30-minute video visit.

The damaging admission: Evernow does not offer scheduled doctor-visit appointments by default — it is a messaging-and-app model. If you specifically want a 30-minute scheduled video visit with a board-certified doctor, Gennev or Midi are the right pick instead. But because Evernow skips the high-touch visit model, they can bundle FDA-approved vaginal cream into a $35/month membership — which is a benefit most readers of this page actually want more than a scheduled visit.

Don’t pick Evernow if: You have a complex medical history needing a comprehensive workup; you are a breast cancer survivor needing oncology coordination; you want medication priced per-product rather than bundled.

Midi Health — best insurance path

Verified (May 27, 2026):

• In-network with most PPO plans
• Self-pay: $250 initial / $150 follow-up
• Most insured patients pay around $50 average out of pocket per visit (Midi’s own published figure)
• Cannot treat Medicaid or Medi-Cal patients
• Not covered by Medicare or Medicare-related plans (can accept Medicare beneficiaries as self-pay, but the beneficiary cannot submit claims)
• Prescribes FDA-approved hormone therapy by default
• Treats vaginal dryness and painful sex; explicitly lists vaginal estrogen cream, ring, and suppository options in its public help center
• All 50 states

Pick Midi if: You have PPO insurance; your painful sex is one of several menopause symptoms (hot flashes, sleep, mood); you want one clinician handling the whole picture.

The damaging admission: Midi has no flat monthly subscription. Cash-pay sticker is high ($250 initial). If you are paying cash and want a predictable subscription, Evernow or Alloy are cheaper. But because Midi bills like a clinical practice instead of a subscription, PPO coverage can turn the high sticker into a much lower real out-of-pocket cost for eligible insured readers.

Don’t pick Midi if: You have Medicaid or Medi-Cal; you have Medicare and need it to pay; you are cash-pay and just want a vaginal cream.

Wisp — fastest cheapest local-only path

Verified (May 27, 2026):

• Menopause consultation: $99 (all 50 states for menopause consult)
• Estradiol vaginal cream: from $20
• Same-day prescription to a local pharmacy if eligible
• HSA/FSA accepted
• FDA-approved estradiol vaginal cream
• Board-certified provider review

Pick Wisp if: Your only or main issue is vaginal — dryness, painful sex, recurrent UTI; you want the lowest-friction defined-symptom checkout.

The damaging admission: Wisp is a one-job tool. If you also have hot flashes, night sweats, sleep disruption, or mood changes, you need a fuller menopause workup — and Wisp is not built for that. Midi, Evernow, or Gennev are the right picks instead. But because Wisp focuses on the local protocol, it can offer one of the lowest-friction, lowest-cost vaginal-estrogen paths on the market.

Don’t pick Wisp if: You have full systemic menopause symptoms; you want one clinician handling the whole midlife picture.

Alloy — best cash-pay with prices and doctor access upfront

Verified (May 27, 2026):

• Estradiol vaginal cream: from $39.99/month, billed every 3 months ($119.97 per shipment)
• Alloy’s vaginal cream product page lists “painful sex” as a primary use case and states the cream is FDA-approved
• Includes $0 unlimited doctor access (per Alloy’s product page)
• Does not accept insurance; HSA/FSA-eligible
• Also offers non-hormonal SSRI (paroxetine) for women who cannot or do not want to use hormones

Pick Alloy if: You are cash-pay; you want to see prices before commitment; you may also want non-hormonal options under one roof; you want messaging access bundled in.

The damaging admission:Alloy does not bundle vaginal cream into a free-cream offer the way Evernow does. For the single goal of “FDA-approved vaginal cream at the lowest cash-pay cost,” Evernow’s 3-month membership wins on raw price. Alloy is not trying to be the cheapest — they are the most transparent.

Don’t pick Alloy if: You have strong PPO insurance (Midi is usually cheaper); your only goal is the cheapest cream (Evernow is cheaper).

MyMenopauseRx — best for insurance + the FDA-approved oral pill (Osphena)

Verified (May 27, 2026):

• Self-pay virtual visit: $99
• Accepts most major insurance plans (copay/coinsurance/deductible apply)
• Has a dedicated “Treat Painful Sex” page on its public site
• Public materials list FDA-approved GSM treatment options including vaginal estrogen, DHEA/prasterone, and ospemifene/Osphena; actual prescribing depends on clinician evaluation
• Listed as the partnered telehealth route on osphena.com (Duchesnay USA)
• Treats GSM, vaginal dryness, painful sex, and low libido alongside systemic menopause symptoms

Pick MyMenopauseRx if: You specifically want to be evaluated for or prescribed Osphena (the oral pill); you have PPO insurance and want a menopause specialist visit billed through your plan; you want a clinic explicitly built around the painful-sex indication.

The damaging admission: MyMenopauseRx is less of a household name than Hers or Alloy. If brand familiarity matters to you, this is not your pick. But because they are the route directly linked from the manufacturer of the FDA-approved oral pill for painful sex, the clinical and commercial path is shorter and cleaner than going through a general menopause platform.

Don’t pick MyMenopauseRx if: You only want vaginal cream and want the cheapest possible cash-pay path (Wisp / Evernow are cheaper); you specifically want a flat-rate subscription model.

Pandia Health — best for Menopause Society Certified clinicians

Verified (May 27, 2026):

• Menopause membership: $34.99/mo (1-year plan), $59/mo (3-mo plan), $69/mo (monthly)
• Medication is not included in the membership
• Accepts most major insurance plans for medication; Pandia’s pharmacy accepts some Medicaid plans for medication
• HSA/FSA accepted
• Clinicians include Menopause Society Certified Practitioners (MSCP)
• Multiple FDA-approved bioidentical delivery methods (creams, patches, rings, suppositories)
• 30-day cancellation notice required; early-cancellation fee may apply

Pick Pandia if: You want a clinician with the MSCP credential; you want continuity and easy refills; your situation is more complex than a basic GSM-only protocol.

The damaging admission:Pandia’s medication is not bundled. Your 90-day total may be higher than Evernow’s because Evernow includes the cream. But Pandia’s clinical bench is stronger on credentials — if the MSCP credential matters to you (and for complex cases, it should), Pandia is built for that.

Don’t pick Pandia if: You want the cheapest sticker price; you might cancel quickly (early-cancellation fee applies).

Gennev — best scheduled doctor-visit model

Verified (May 27, 2026):

• Initial visit: 30-minute video appointment with board-certified, menopause-trained doctor
• Self-pay: $250 initial / $199 follow-up
• Insurance accepted with standard copay/deductible
• FDA-approved hormone therapy by default; does not recommend compounded hormones as a default
• All 50 states for video appointments

Pick Gennev if: You want a structured, scheduled doctor visit; your situation is complex enough that a real clinical conversation matters more than the price.

The damaging admission:Gennev’s per-visit price is the highest cash-pay option in this comparison. If you want the lowest entry cost, look elsewhere. But for breast cancer survivors and women with complex histories, a 30-minute board-certified doctor visit is worth the higher sticker.

Don’t pick Gennev if: You want the lowest cost; you want a subscription model.

Hers — familiar consumer brand with a 12-month plan

Verified (May 27, 2026):

• 12-month oral plan: $79/mo (per Hers’ published educational content; verify Hers-specific pricing at checkout)
• 12-month patch plan: $134/mo per Reuters reporting in April 2026
• Vaginal estrogen cream available per Hers’ published menopause page
• FDA-approved estradiol (oral, patch, vaginal cream) and oral progesterone
• Not available in all 50 states (per Hers’ own disclosure)
• HSA/FSA eligible

Pick Hers if: You already use Hers for other products and want one platform; you want a 12-month price lock; you are in a supported state.

The damaging admission: Hers is brand-new in menopause. The state-availability gap is the real trade-off. But because Hers spent years building its consumer-health platform before adding menopause, the intake experience is dramatically smoother than newer entrants.

Don’t pick Hers if: You are in an unsupported state; you want insurance billing.

Winona — only if you specifically want compounded

Verified (May 27, 2026):

• Vaginal estrogen cream: from $89/month (compounded)
• Estrogen patches: from $149/mo (Winona states FDA-approved)
• Oral estrogen tablets: from $54/mo (Winona states FDA-approved)
• Progesterone capsules: from $39/mo (Winona states FDA-approved)
• No membership fee; pay per medication
• Does not accept insurance; HSA/FSA-eligible
• Board-certified OB-GYN prescribers; no blood work required to prescribe

Pick Winona if: Your clinician has identified a specific medical reason for a compounded formulation (allergy to inactive ingredient, dose not commercially available); you want both compounded and FDA-approved options under one roof.

Don’t pick Winona if: You are a first-time HRT patient for whom FDA-approved vaginal estrogen is the appropriate starting protocol — which is most readers of this page.

What if lube isn’t working anymore?

If lube was working a year ago and is not working now, it is not because you “did lube wrong.” It is because the tissue your lube was helping is now drier, thinner, less elastic than it was a year ago. That is GSM doing what GSM does: progressing without treatment.

• Lubricant = friction reducer during sex.
• Vaginal moisturizer (like Replens, Hyalo Gyn) = ongoing tissue hydration, used 2 to 3 times per week between sex.
• Vaginal estrogen / Intrarosa / Osphena = targets the underlying GSM tissue changes, not just the moment.

If you have already tried lube and moisturizer and you are still here, you have earned the next step. That is the prescription conversation.

The exact phrase to bring to your clinician

That sentence tells a clinician you have done the homework, you know the protocol, and you want to be heard. It is the difference between a 5-minute brush-off and an actual treatment plan.

How long does vaginal estrogen take to work?

• Weeks 1–2: Some women notice early improvement in dryness; pain often has not resolved yet.
• Weeks 3–8: Tissue thickening progresses with consistent use. Most women notice meaningful improvement in this window.
• Weeks 8–12: Full effect typically by week 12.
• After 12 weeks with no improvement: Time to talk to your clinician about a different formulation (cream to tablet to ring), adding pelvic floor PT, or considering prasterone or ospemifene instead.

How we ranked these clinics

The full methodology lives at our methodology page. How this page differs from our general homepage ranking:

1. Symptom fit: Does the provider visibly address painful sex, dyspareunia, vaginal dryness, GSM — not just generic menopause?
2. Treatment menu visibility: Does the provider visibly offer vaginal estrogen (cream, tablet, ring, insert), DHEA (Intrarosa), ospemifene (Osphena), and pelvic-floor referral pathways?
3. Price and access clarity: Is pricing transparent before intake? Are state availability, insurance, and medication costs visible?
4. Clinical-safety fit: Does the model support contraindication screening, follow-up, and referral out when needed?

We do not weight a provider’s affiliate program in our ranking. Where we add an active affiliate relationship later, the link will be labeled. For the broader head-to-head between the most-compared providers, see Midi vs Alloy vs Winona vs Evernow. For broader cost coverage by medication type, see HRT cost in 2026. For the medication category itself, see Vaginal Estrogen.

Frequently asked questions

Still not sure which clinic is right for you?

Take our free 60-second matching quiz. You’ll answer a few questions about your insurance, your symptoms (including whether this is vaginal-only or also systemic), your state, and your breast-cancer history — and we’ll match you to the best-fit clinic with a backup option, plus the specific questions to ask in your first consultation.

Free, takes about 60 seconds, and we don’t share your information with providers without your permission.

Why we built this page

The HRT Index is an independent comparison resource for HRT telehealth providers. We started this because nobody was publishing real prices, real state-availability data, and real cost math for specific symptoms — in one place. We do.

We re-verify pricing monthly for the top providers and quarterly for the full roster. If you spot something out of date, email us — we want to fix it.

We may earn a commission if you sign up with a provider through a labeled affiliate link. This does not influence our rankings. We’ve published our methodology so you can see exactly how we evaluate each provider.

This page was researched and written by The HRT Index editorial team. It has not been reviewed by a medical doctor. We’re a research and comparison resource — for medical advice, see a licensed clinician.

Last verified: May 27, 2026. Next refresh: June 27, 2026.

Sources

Provider pricing and policies (verified May 27, 2026):

• Evernow pricing and membership: evernow.com
• Midi Health pricing and insurance: joinmidi.com
• Wisp menopause consult: hellowisp.com
• Alloy vaginal cream and pricing: myalloy.com
• MyMenopauseRx painful sex page: mymenopauserx.com
• Pandia Health menopause membership: pandiahealth.com
• Gennev menopause care: gennev.com
• Hers menopause care: forhers.com
• Winona shop and product menu: bywinona.com
• Osphena manufacturer (Duchesnay USA) — partnered telehealth route: osphena.com

Medical and regulatory references:

• U.S. Food and Drug Administration. “FDA Approves Labeling Changes to Menopausal Hormone Therapy Products.” February 12, 2026.
• U.S. Department of Health and Human Services. “HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy.” November 10, 2025.
• U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.”
• ACOG Clinical Consensus No. 6. “Compounded Bioidentical Menopausal Hormone Therapy.” Obstetrics & Gynecology, November 2023.
• ACOG Committee Opinion #659 / 2021 Clinical Consensus — urogenital symptoms in women with a history of estrogen-dependent breast cancer.
• The Menopause Society position statement on genitourinary syndrome of menopause.
• Brænder M et al. “Vaginal estradiol and risk of recurrent ischemic stroke among postmenopausal women.” Stroke, 2025 (Danish registry analysis).
• Sarrel PM et al. Journal of Clinical Oncology — lidocaine 4% in breast cancer survivors with vestibular pain.
• Reuters. “Hims & Hers says it has steady estrogen patch supply amid U.S. shortages.” April 2026.
• DailyMed label — Prasterone (Intrarosa). Contraindications section.
• JAMA Health Forum — decline in hormone therapy use among postmenopausal U.S. women.